Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 216

1.

Low CD38 Identifies Progenitor-like Inflammation-Associated Luminal Cells that Can Initiate Human Prostate Cancer and Predict Poor Outcome.

Liu X, Grogan TR, Hieronymus H, Hashimoto T, Mottahedeh J, Cheng D, Zhang L, Huang K, Stoyanova T, Park JW, Shkhyan RO, Nowroozizadeh B, Rettig MB, Sawyers CL, Elashoff D, Horvath S, Huang J, Witte ON, Goldstein AS.

Cell Rep. 2016 Dec 6;17(10):2596-2606. doi: 10.1016/j.celrep.2016.11.010.

PMID:
27926864
2.

Preoperative Three-Dimensional Strain Imaging Identifies Reduction in Left Ventricular Function and Predicts Outcomes After Cardiac Surgery.

Howard-Quijano K, Salem A, Barkulis C, Mazor E, Scovotti JC, Ho JK, Shemin RJ, Grogan T, Elashoff D, Mahajan A.

Anesth Analg. 2016 Oct 24. [Epub ahead of print]

PMID:
27782943
3.

Oxidized lipoproteins are associated with markers of inflammation and immune activation in HIV-1 infection.

Kelesidis T, Jackson N, McComsey GA, Wang X, Elashoff D, Dube MP, Brown TT, Yang OO, Stein JH, Currier JS.

AIDS. 2016 Nov 13;30(17):2625-2633.

PMID:
27603288
4.

Voriconazole increases the risk for cutaneous squamous cell carcinoma after lung transplantation.

Kolaitis NA, Duffy E, Zhang A, Lo M, Barba DT, Chen M, Soriano T, Hu J, Nabili V, Saggar R, Sayah DM, DerHovanessian A, Shino MY, Lynch JP 3rd, Kubak BM, Ardehali A, Ross DJ, Belperio JA, Elashoff D, Saggar R, Weigt SS.

Transpl Int. 2016 Sep 28. doi: 10.1111/tri.12865. [Epub ahead of print]

PMID:
27678492
5.

Elimination of Routine Contact Precautions for Endemic Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococcus: A Retrospective Quasi-Experimental Study.

Martin EM, Russell D, Rubin Z, Humphries R, Grogan TR, Elashoff D, Uslan DZ.

Infect Control Hosp Epidemiol. 2016 Nov;37(11):1323-1330.

PMID:
27457254
6.

Keratin 13 Is Enriched in Prostate Tubule-Initiating Cells and May Identify Primary Prostate Tumors that Metastasize to the Bone.

Liu S, Cadaneanu RM, Zhang B, Huo L, Lai K, Li X, Galet C, Grogan TR, Elashoff D, Freedland SJ, Rettig M, Aronson WJ, Knudsen BS, Lewis MS, Garraway IP.

PLoS One. 2016 Oct 6;11(10):e0163232. doi: 10.1371/journal.pone.0163232.

7.

Initiating Diagnostic Studies on Patients With Abdominal Pain in the Waiting Room Decreases Time Spent in an Emergency Department Bed: A Randomized Controlled Trial.

Begaz T, Elashoff D, Grogan TR, Talan D, Taira BR.

Ann Emerg Med. 2016 Aug 12. pii: S0196-0644(16)30360-2. doi: 10.1016/j.annemergmed.2016.06.040. [Epub ahead of print]

PMID:
27527398
8.

Improvement in HDL Function in Early Rheumatoid Arthritis Patients Treated with Methotrexate Monotherapy or Combination Therapy in the TEAR Trial.

Charles-Schoeman C, Lee YY, Shahbazian A, Wang X, Elashoff D, Curtis JR, Navarro-Millán I, Yang S, Chen L, Cofield SS, Moreland LW, Paulus H, O'Dell J, Bathon J, Bridges SL Jr, Reddy ST.

Arthritis Rheumatol. 2016 Aug 2. doi: 10.1002/art.39833. [Epub ahead of print]

PMID:
27483410
9.

Accessibility to Oral Antiviral Therapy for Patients with Chronic Hepatitis C in the United States.

Saab S, Jimenez M, Fong T, Wu C, Bau S, Jamal Z, Grotts J, Elashoff D.

J Clin Transl Hepatol. 2016 Jun 28;4(2):76-82. doi: 10.14218/JCTH.2016.00011.

10.

Effect of Dietary Omega-3 Fatty Acids on Tumor-Associated Macrophages and Prostate Cancer Progression.

Liang P, Henning SM, Schokrpur S, Wu L, Doan N, Said J, Grogan T, Elashoff D, Cohen P, Aronson WJ.

Prostate. 2016 Oct;76(14):1293-302. doi: 10.1002/pros.23218.

PMID:
27338236
11.

Examining the Impact of Patient-Reported Hope for Improvement and Patient Satisfaction with Clinician/Treatment on the Outcome of Major Depressive Disorder Treatment.

IsHak WW, Vilhauer J, Kwock R, Wu F, Gohar S, Collison K, Thomas SN, Naghdechi L, Elashoff D.

Int Neuropsychiatr Dis J. 2016;7(2). pii: INDJ.26203.

12.

MicroRNA-19a/b mediates grape seed procyanidin extract-induced anti-neoplastic effects against lung cancer.

Mao JT, Xue B, Smoake J, Lu QY, Park H, Henning SM, Burns W, Bernabei A, Elashoff D, Serio KJ, Massie L.

J Nutr Biochem. 2016 Aug;34:118-25. doi: 10.1016/j.jnutbio.2016.05.003.

PMID:
27289489
13.

Optimizing Effect Sizes With Imaging Enrichment and Outcome Choices for Mild Alzheimer Disease Clinical Trials.

Chang TS, Teng E, Elashoff D, Grill JD; Alzheimer’s Disease Neuroimaging Initiative..

Alzheimer Dis Assoc Disord. 2016 May 18. [Epub ahead of print]

PMID:
27196535
14.

Age-related Morbidity and Mortality After Transjugular Intrahepatic Portosystemic Shunts.

Suraweera D, Jimenez M, Viramontes M, Jamal N, Grotts J, Elashoff D, Lee EW, Saab S.

J Clin Gastroenterol. 2016 May 6. [Epub ahead of print]

PMID:
27159421
15.

Developmental trajectories of cerebral blood flow and oxidative metabolism at baseline and during working memory tasks.

Jog MA, Yan L, Kilroy E, Krasileva K, Jann K, LeClair H, Elashoff D, Wang DJ.

Neuroimage. 2016 Jul 1;134:587-96. doi: 10.1016/j.neuroimage.2016.04.035.

PMID:
27103136
16.

Lung Transplant Outcomes in Systemic Sclerosis with Significant Esophageal Dysfunction. A Comprehensive Single-Center Experience.

Miele CH, Schwab K, Saggar R, Duffy E, Elashoff D, Tseng CH, Weigt S, Charan D, Abtin F, Johannes J, Derhovanessian A, Conklin J, Ghassemi K, Khanna D, Siddiqui O, Ardehali A, Hunter C, Kwon M, Biniwale R, Lo M, Volkmann E, Torres Barba D, Belperio JA, Sayah D, Mahrer T, Furst DE, Kafaja S, Clements P, Shino M, Gregson A, Kubak B, Lynch JP 3rd, Ross D, Saggar R.

Ann Am Thorac Soc. 2016 Jun;13(6):793-802. doi: 10.1513/AnnalsATS.201512-806OC.

PMID:
27078625
17.

Curing Hepatitis C in Liver Transplant Recipients Is Associated with Changes in Immunosuppressant Use.

Saab S, Rheem J, Jimenez M, Bau S, Choi G, Durazo F, El Kabany M, Han S, Farid A, Jamal N, Grotts J, Elashoff D, Busuttil RW.

J Clin Transl Hepatol. 2016 Mar 28;4(1):32-8. doi: 10.14218/JCTH.2016.00001.

18.

Routine Laboratory Blood Tests May Diagnose Significant Fibrosis in Liver Transplant Recipients with Chronic Hepatitis C: A 10 Year Experience.

Sheen V, Nguyen H, Jimenez M, Agopian V, Vangala S, Elashoff D, Saab S.

J Clin Transl Hepatol. 2016 Mar 28;4(1):20-5. doi: 10.14218/JCTH.2015.00034.

19.

Disclosure of amyloid status is not a barrier to recruitment in preclinical Alzheimer's disease clinical trials.

Grill JD, Zhou Y, Elashoff D, Karlawish J.

Neurobiol Aging. 2016 Mar;39:147-53. doi: 10.1016/j.neurobiolaging.2015.11.007.

PMID:
26923411
20.

Performance of Gout Impact Scale in a longitudinal observational study of patients with gout.

Wallace B, Khanna D, Aquino-Beaton C, Singh JA, Duffy E, Elashoff D, Khanna PP.

Rheumatology (Oxford). 2016 Jun;55(6):982-90. doi: 10.1093/rheumatology/kew007.

Items per page

Supplemental Content

Loading ...
Support Center